These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31689349)

  • 21. The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines.
    Wilckens V; Kannengiesser K; Hoxhold K; Frenkel C; Kucharzik T; Maaser C
    Scand J Gastroenterol; 2011 Jul; 46(7-8):855-61. PubMed ID: 21506630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccinations in patients with inflammatory bowel disease.
    Macaluso FS; Liguori G; Galli M
    Dig Liver Dis; 2021 Dec; 53(12):1539-1545. PubMed ID: 34116972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updates on vaccinating the inflammatory bowel disease patient.
    Zullow S; Farraye FA
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):229-239. PubMed ID: 30791761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
    Magro F; Santos-Antunes J; Albuquerque A; Vilas-Boas F; Macedo GN; Nazareth N; Lopes S; Sobrinho-Simões J; Teixeira S; Dias CC; Cabral J; Sarmento A; Macedo G
    Inflamm Bowel Dis; 2013 Jul; 19(8):1710-6. PubMed ID: 23574759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany.
    Cagol L; Seitel T; Ehrenberg S; Frivolt K; Krahl A; Lainka E; Gerner P; Lenhartz H; Vermehren J; Radke M; Trenkel S; Mayer B; Koletzko S; Debatin KM; Mertens T; Posovszky C
    Vaccine; 2020 Feb; 38(7):1810-1817. PubMed ID: 31879123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.
    Borman ZA; Côté-Daigneault J; Colombel JF
    Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1101-1108. PubMed ID: 30277409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Decade of Varicella Screening Within a Paediatric Inflammatory Bowel Disease Population.
    Harris RE; Curtis L; Hegde V; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
    J Crohns Colitis; 2020 Jun; 14(5):608-616. PubMed ID: 31889176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ideal vaccination strategy in inflammatory bowel disease].
    Lee CK
    Korean J Gastroenterol; 2015 Mar; 65(3):159-64. PubMed ID: 25797379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease.
    Lenti MV; Mengoli C; Vernero M; Aronico N; Conti L; Borrelli de Andreis F; Cococcia S; Di Sabatino A
    Front Immunol; 2020; 11():485. PubMed ID: 32269571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunisation in children and adolescents with inflammatory bowel disease.
    Banaszkiewicz A; Radzikowski A; Albrecht P
    Adv Med Sci; 2015 Mar; 60(1):144-7. PubMed ID: 25689276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.
    Fiorino G; Peyrin-Biroulet L; Naccarato P; Szabò H; Sociale OR; Vetrano S; Fries W; Montanelli A; Repici A; Malesci A; Danese S
    Inflamm Bowel Dis; 2012 Jun; 18(6):1042-7. PubMed ID: 21674732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Pham HV; Hasan I; Udaltsova N; Pham K; Abramson O; Armstrong MA; Postlethwaite D; Li D
    Dig Dis Sci; 2018 Jan; 63(1):209-217. PubMed ID: 28836068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.
    Altunöz ME; Senateş E; Yeşil A; Calhan T; Ovünç AO
    Dig Dis Sci; 2012 Apr; 57(4):1039-44. PubMed ID: 22147248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical guide to vaccinating the inflammatory bowel disease patient.
    Wasan SK; Baker SE; Skolnik PR; Farraye FA
    Am J Gastroenterol; 2010 Jun; 105(6):1231-8. PubMed ID: 20104218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients.
    Ferreiro-Iglesias R; Piqueras M; Ricart E; Sempere L; Roca M; Martín de Carpi J; Benítez O; Zabana Y; Mañosa M; Rodríguez-Moranta F; Barreiro-de Acosta M;
    Gastroenterol Hepatol; 2022 Dec; 45(10):805-818. PubMed ID: 35577225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.
    Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ
    World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.
    Carpio D; Jauregui-Amezaga A; de Francisco R; de Castro L; Barreiro-de Acosta M; Mendoza JL; Mañosa M; Ollero V; Castro B; González-Conde B; Hervías D; Sierra Ausin M; Sancho Del Val L; Botella-Mateu B; Martínez-Cadilla J; Calvo M; Chaparro M; Ginard D; Guerra I; Maroto N; Calvet X; Fernández-Salgado E; Gordillo J; Rojas Feria M;
    J Crohns Colitis; 2016 Oct; 10(10):1186-93. PubMed ID: 26802085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
    Gehlert T; Devergne O; Niedobitek G
    J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.
    Mazzola G; Macaluso FS; Adamoli L; Renna S; Cascio A; Orlando A
    J Infect; 2017 May; 74(5):433-441. PubMed ID: 28263759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.